These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Serial measurements of peripheral vascular reactivity and exercise capacity in congestive heart failure and after heart transplantation. Hognestad A; Holm T; Simonsen S; Kjekshus J; Andreassen AK J Card Fail; 2005 Aug; 11(6):447-54. PubMed ID: 16105636 [TBL] [Abstract][Full Text] [Related]
23. Augmented response in plasma atrial natriuretic peptide to dynamic exercise in patients with congestive heart failure. Kato M; Kinugawa T; Omodani H; Osaki S; Ogino K; Hisatome I; Miyakoda H; Fujimoto Y Jpn Circ J; 1996 Dec; 60(12):909-16. PubMed ID: 8996680 [TBL] [Abstract][Full Text] [Related]
24. Acute regional vascular effects of intravenous captopril in a rat model of myocardial infarction and failure. Drexler H; Depenbusch JW; Truog AG; Zelis R; Flaim SF J Pharmacol Exp Ther; 1987 Apr; 241(1):13-9. PubMed ID: 3553536 [TBL] [Abstract][Full Text] [Related]
25. Efficacy of oral angiotensin-converting enzyme inhibition with captopril therapy in severe chronic normotensive congestive heart failure. Awan NA; Evenson MK; Needham KE; Win A; Mason DT Am Heart J; 1981 Jan; 101(1):22-31. PubMed ID: 6257100 [TBL] [Abstract][Full Text] [Related]
26. The contribution of the renin-angiotensin system to limb vasoregulation in patients with heart failure: observations during orthostasis and alpha-adrenergic blockade. Creager MA; Faxon DP; Rockwell SM; Gavras H; Coffman JD Clin Sci (Lond); 1985 Jun; 68(6):659-67. PubMed ID: 2485267 [TBL] [Abstract][Full Text] [Related]
27. Regional and systemic metabolic effects of angiotensin-converting enzyme inhibition during exercise in patients with severe heart failure. Kugler J; Maskin C; Frishman WH; Sonnenblick EH; LeJemtel TH Circulation; 1982 Dec; 66(6):1256-61. PubMed ID: 6291801 [TBL] [Abstract][Full Text] [Related]
28. Muscle metaboreflex is blunted with reduced vascular resistance response of nonexercised limb in patients with chronic heart failure. Kon H; Nakamura M; Arakawa N; Hiramori K J Card Fail; 2004 Dec; 10(6):503-10. PubMed ID: 15599841 [TBL] [Abstract][Full Text] [Related]
29. Captopril versus placebo in congestive heart failure: effects on oxygen delivery to exercising skeletal muscle. Timmis AD; Bojanowski LM; Najm YC; Nelson DJ; Gosling RG Eur Heart J; 1987 Dec; 8(12):1295-304. PubMed ID: 3325289 [TBL] [Abstract][Full Text] [Related]
30. Regional specificity of peak hyperemic response in patients with congestive heart failure: correlation with peak aerobic capacity. Jondeau G; Katz SD; Toussaint JF; Dubourg O; Monrad ES; Bourdarias JP; LeJemtel TH J Am Coll Cardiol; 1993 Nov; 22(5):1399-402. PubMed ID: 8227797 [TBL] [Abstract][Full Text] [Related]
31. Evidence for structural alterations in resistance arteries of patients with severe congestive heart failure. Mengden T; Douven C; Vetter H; Düsing R J Vasc Res; 1999; 36(3):229-34. PubMed ID: 10393509 [TBL] [Abstract][Full Text] [Related]
32. Central and peripheral components of chronic heart failure: determinants of exercise tolerance. Florea VG; Mareyev VY; Achilov AA; Popovici MI; Coats AJ; Belenkov YN Int J Cardiol; 1999 Jul; 70(1):51-6. PubMed ID: 10402045 [TBL] [Abstract][Full Text] [Related]
33. Peripheral hemodynamic and humoral effects of oral zofenopril calcium (SQ. 26,991) in patients with congestive heart failure. Borghi C; Magelli C; Boschi S; Costa FV; Capelli M; Varani E; Magnani B; Ambrosioni E J Clin Pharmacol; 1989 Dec; 29(12):1077-82. PubMed ID: 2533220 [TBL] [Abstract][Full Text] [Related]
34. Dependence of enhanced maximal exercise performance on increased peak skeletal muscle perfusion during long-term captopril therapy in heart failure. Mancini DM; Davis L; Wexler JP; Chadwick B; LeJemtel TH J Am Coll Cardiol; 1987 Oct; 10(4):845-50. PubMed ID: 3309004 [TBL] [Abstract][Full Text] [Related]
35. Peripheral haemodynamic effects of perindopril compared in patients with congestive heart failure and in normal volunteers. Thuillez C; Richard C; Richer C; Loueslati H; Perret L; Auzépy P; Giudicelli JF J Hypertens Suppl; 1988 Dec; 6(3):S41-3. PubMed ID: 2852235 [TBL] [Abstract][Full Text] [Related]
36. Captopril: an update review of its pharmacological properties and therapeutic efficacy in congestive heart failure. Romankiewicz JA; Brogden RN; Heel RC; Speight TM; Avery GS Drugs; 1983 Jan; 25(1):6-40. PubMed ID: 6218982 [TBL] [Abstract][Full Text] [Related]
37. Potent and long-lasting vasodilatory effects of adrenomedullin in humans. Comparisons between normal subjects and patients with chronic heart failure. Nakamura M; Yoshida H; Makita S; Arakawa N; Niinuma H; Hiramori K Circulation; 1997 Mar; 95(5):1214-21. PubMed ID: 9054852 [TBL] [Abstract][Full Text] [Related]
38. Exercise-induced vasodilation in forearm circulation of normal subjects and patients with congestive heart failure: role of endothelium-derived nitric oxide. Katz SD; Krum H; Khan T; Knecht M J Am Coll Cardiol; 1996 Sep; 28(3):585-90. PubMed ID: 8772743 [TBL] [Abstract][Full Text] [Related]
39. Skeletal muscle blood flow, metabolism and morphology in chronic congestive heart failure and effects of short- and long-term angiotensin-converting enzyme inhibition. Drexler H; Hiroi M; Riede U; Banhardt U; Meinertz T; Just H Am J Cardiol; 1988 Sep; 62(8):82E-85E. PubMed ID: 3046293 [TBL] [Abstract][Full Text] [Related]
40. Sympathetic reflex control of skeletal muscle blood flow in patients with congestive heart failure: evidence for beta-adrenergic circulatory control. Kassis E; Jacobsen TN; Mogensen F; Amtorp O Circulation; 1986 Nov; 74(5):929-38. PubMed ID: 3021356 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]